Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (11)
P 4 (1)

Trial Status

Completed5
Unknown4
Recruiting4
Not Yet Recruiting3
Withdrawn1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07538193Not ApplicableNot Yet Recruiting

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

NCT06253065Completed

Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer

NCT07362485Not ApplicableRecruiting

Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)

NCT07319104Not Yet Recruiting

Liquid Biopsy in Early Colorectal Lesions

NCT07146295Not ApplicableRecruiting

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

NCT06623578Not ApplicableRecruiting

Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC

NCT06517979Recruiting

Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis

NCT07042984Not Yet Recruiting

RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer

NCT06947096Enrolling By Invitation

Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients

NCT01962324Not ApplicableCompleted

Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

NCT04116125Not ApplicableUnknown

Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial

NCT02341170Not ApplicableWithdrawn

HS-PCI in Locally Advanced Adenocarcinoma of the Lung

NCT02789371Not ApplicableUnknown

Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions

NCT02167087Not ApplicableCompleted

Sentinel Node Mapping With Indocyanine Green in Colon Cancer: a Feasibility Trial and a Descriptive Serie.

NCT02327065Not ApplicableUnknown

Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion

NCT00288821Completed

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

NCT01103557Not ApplicableCompleted

Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma

NCT00185029Phase 4Unknown

MR-Lymphography and Lymph Node Staging in Prostate Cancer

Showing all 18 trials

Research Network

Activity Timeline